ID29573A - Gen ly6h - Google Patents

Gen ly6h

Info

Publication number
ID29573A
ID29573A IDW20010739A ID20010739A ID29573A ID 29573 A ID29573 A ID 29573A ID W20010739 A IDW20010739 A ID W20010739A ID 20010739 A ID20010739 A ID 20010739A ID 29573 A ID29573 A ID 29573A
Authority
ID
Indonesia
Prior art keywords
gene
ly6h
gen
expression vector
product
Prior art date
Application number
IDW20010739A
Other languages
English (en)
Inventor
Masato Horie
Keiichi Okutomi
Yoshihiro Taniguchi
Mikio Suzuki
Yutaka Ohbuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of ID29573A publication Critical patent/ID29573A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
IDW20010739A 1998-09-17 1999-09-16 Gen ly6h ID29573A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26355098 1998-09-17

Publications (1)

Publication Number Publication Date
ID29573A true ID29573A (id) 2001-09-06

Family

ID=17391112

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010739A ID29573A (id) 1998-09-17 1999-09-16 Gen ly6h

Country Status (16)

Country Link
US (4) US7432363B2 (id)
EP (1) EP1114861B8 (id)
JP (1) JP4403443B2 (id)
KR (1) KR100640265B1 (id)
CN (1) CN1240834C (id)
AT (1) ATE346923T1 (id)
AU (1) AU767878B2 (id)
BR (1) BR9913850A (id)
CA (1) CA2342770C (id)
CY (1) CY1107552T1 (id)
DE (1) DE69934239T8 (id)
DK (1) DK1114861T3 (id)
ES (1) ES2276531T3 (id)
ID (1) ID29573A (id)
PT (1) PT1114861E (id)
WO (1) WO2000017345A1 (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29573A (id) * 1998-09-17 2001-09-06 Otsuka Pharma Co Ltd Gen ly6h
EP1575916B1 (en) * 2001-08-31 2013-05-22 The Rockefeller University Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PL1976877T5 (pl) 2005-11-30 2017-09-29 Abbvie Inc Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
RU2442793C2 (ru) 2005-11-30 2012-02-20 Эбботт Лэборетриз АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
RU2502806C2 (ru) * 2007-02-22 2013-12-27 Дженентек, Инк. Способы выявления воспалительного заболевания кишечника
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
WO2011016861A2 (en) 2009-08-05 2011-02-10 Intra-Cellular Therapies, Inc. Novel regulatory proteins and inhibitors
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US20140286910A1 (en) * 2013-03-19 2014-09-25 Nikolai Tankovich Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity
CN105385754B (zh) * 2015-10-28 2018-11-06 北京泱深生物信息技术有限公司 一种与胆管癌相关的分子标记物
WO2019006162A1 (en) * 2017-06-28 2019-01-03 Bluefin Biomedicine, Inc. ANTI-LY6H ANTIBODIES AND CONJUGATES ANTIBODY-MEDICINE
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
KR102232200B1 (ko) * 2019-03-13 2021-03-25 아주대학교산학협력단 알츠하이머치매 진단 바이오마커
KR20210124308A (ko) 2019-01-30 2021-10-14 트루바인딩 아이엔씨. 항-gal3 항체 및 이의 용도
MX2022014786A (es) 2020-05-26 2023-01-16 Truebinding Inc Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011912A (en) 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
JPH0348696A (ja) * 1989-07-14 1991-03-01 Toray Ind Inc ヒトリンパ球表面抗原およびそれをコードする遺伝子
AU4594696A (en) * 1995-11-13 1997-06-05 Human Genome Sciences, Inc. Human stem cell antigen 2
AU2095299A (en) * 1997-12-31 1999-07-19 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
ID29573A (id) * 1998-09-17 2001-09-06 Otsuka Pharma Co Ltd Gen ly6h

Also Published As

Publication number Publication date
DK1114861T3 (da) 2007-03-19
US7582732B2 (en) 2009-09-01
AU5651899A (en) 2000-04-10
WO2000017345A1 (en) 2000-03-30
EP1114861B8 (en) 2008-10-01
US20080275218A1 (en) 2008-11-06
JP4403443B2 (ja) 2010-01-27
CN1240834C (zh) 2006-02-08
EP1114861B1 (en) 2006-11-29
US20100261880A1 (en) 2010-10-14
HK1038380A1 (en) 2002-03-15
CA2342770A1 (en) 2000-03-30
CN1318099A (zh) 2001-10-17
US7432363B2 (en) 2008-10-07
DE69934239D1 (de) 2007-01-11
US20040254340A1 (en) 2004-12-16
ATE346923T1 (de) 2006-12-15
CA2342770C (en) 2011-06-21
DE69934239T2 (de) 2007-06-28
AU767878B2 (en) 2003-11-27
CY1107552T1 (el) 2013-03-13
KR100640265B1 (ko) 2006-10-31
DE69934239T8 (de) 2007-12-06
EP1114861A4 (en) 2004-10-13
EP1114861A1 (en) 2001-07-11
KR20010085801A (ko) 2001-09-07
US20090017479A1 (en) 2009-01-15
PT1114861E (pt) 2007-01-31
BR9913850A (pt) 2001-10-23
ES2276531T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
CY1107552T1 (el) Ly6h γονιδιο
DE69636866D1 (en) Reverse "two-hybrid"-systeme
WO1999053061A3 (en) Tumor associated nucleic acids and uses therefor
EP0804609A4 (en) NEW GENES OF RESPONSE p53
DE69635207D1 (de) Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
ATE394484T1 (de) Smad 6 und dessen anwendungen
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
FI972333A0 (fi) Entsymaattiset DNA-molekyylit
WO2002004677A3 (en) Methods for diagnosis and treatment of psychiatric disorders
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
IL122884A0 (en) Enamel matrix related polypeptide
DE69839765D1 (de) Lage-1 tumor-assozierte nukleinsäuren
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
WO2004003170A3 (en) Agents capable of inhibiting ras and uses thereof
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same
EP0723014A3 (en) cDNA of DOCK180 gene and DOCK180 protein
AU2002314193A1 (en) Identification of ses-1 and the uses of the same
WO2003051174A3 (en) Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
WO2000008143A3 (de) Gen isoliert auf dem kurzen arm des menschlichen chromosoms 17
IL142664A0 (en) Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same
DE69519654D1 (de) htFIIIA Gen